[go: up one dir, main page]

JO1809B1 - Therapeutic agent - Google Patents

Therapeutic agent

Info

Publication number
JO1809B1
JO1809B1 JO19941809A JOP19941809A JO1809B1 JO 1809 B1 JO1809 B1 JO 1809B1 JO 19941809 A JO19941809 A JO 19941809A JO P19941809 A JOP19941809 A JO P19941809A JO 1809 B1 JO1809 B1 JO 1809B1
Authority
JO
Jordan
Prior art keywords
optionally substituted
alkyl
formula
alkylene chain
alkyl groups
Prior art date
Application number
JO19941809A
Other languages
Arabic (ar)
Inventor
جون هاريس بول
جون هيل ديفيد
Original Assignee
جون هاريس بول
جون هيل ديفيد
ذي بوتس كومباني ال سي
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by جون هاريس بول, جون هيل ديفيد, ذي بوتس كومباني ال سي filed Critical جون هاريس بول
Priority to JO19941809A priority Critical patent/JO1809B1/en
Application granted granted Critical
Publication of JO1809B1 publication Critical patent/JO1809B1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compounds of formula I and pharmaceutically acceptable salts thereof in which m is 0, 1 or 2; n is 2, 3, 4 or 5; X is carbonyl or a group of formula II in which R5 is H or alkyl; Y is an alkylene chain optionally substituted by one or more alkyl groups; Z is an alkylene chain containing 2 to 5 carbon atoms optionally substituted by one or more alkyl groups; R is phenyl optionally substituted by one or more halo substituents or R is naphthyl; and R1 and R2, which are the same or different, are H, alkyl, or arylalkyl, provided that when R1 is benzyl, R2 is H or methyl; have utility in the treatment of depression, anxiety, Parkinson’s disease, obesity, cognitive disorders, seizures, neurological disorders such as epilepsy, and as neuroprotective agents to protect against conditions such as stroke
JO19941809A 1994-11-05 1994-11-05 Therapeutic agent JO1809B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JO19941809A JO1809B1 (en) 1994-11-05 1994-11-05 Therapeutic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JO19941809A JO1809B1 (en) 1994-11-05 1994-11-05 Therapeutic agent

Publications (1)

Publication Number Publication Date
JO1809B1 true JO1809B1 (en) 1995-07-05

Family

ID=48142174

Family Applications (1)

Application Number Title Priority Date Filing Date
JO19941809A JO1809B1 (en) 1994-11-05 1994-11-05 Therapeutic agent

Country Status (1)

Country Link
JO (1) JO1809B1 (en)

Similar Documents

Publication Publication Date Title
GB9705428D0 (en) Therapeutic agents
FR2734816B1 (en) NOVEL ARYL (ALKYL) PROPYLAMIDES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NO951797L (en) Therapeutic agents
NZ335733A (en) 6-phenylpyridyl-2-amine derivatives useful as nitric oxide synthase inhibitors
NZ334600A (en) Thienopyrimidines inhibiting phosphodiesterase V for treating cardiovascular disease and impotency
KR940005534A (en) Arylglycineamide derivative, preparation method thereof and therapeutic agent for urination disorder containing same as active ingredient
MY110773A (en) 1-arylcycloalky1 sulphides, sulphoxides and sulphones, processes for their preparation, and their use in the treatment of depression, anxiety and parkinson''s disease.
JO1809B1 (en) Therapeutic agent
CA2162706A1 (en) 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of depression, anxiety and parkinson's disease
PT1049672E (en) DERIVATIVES OF AZETIDINOCARBOXAMIDE FOR THE TREATMENT OF DISORDERS OF THE SNC
AU2178199A (en) Azetidinecarboxamide derivatives for the treatment of cns disorders
ES2116880A1 (en) Use of arylpiperazine derivatives for the treatment of parkinson's disease and psychosis
PT1049670E (en) AZETIDINOCARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF CNS DISTURBACTIONS
JO1785B1 (en) Therapeutic agent
JO1815B1 (en) Therapeutic agents